Skip to main content

AMGEN INC

For the period ended Jun 30, 2026. Filed Aug 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 5, 2026

AMGN$465.230.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

Three months endedJune 30,Six months endedJune 30,
2026202520262025
Revenues:
Product sales$9,537$8,771$17,755$16,644
Other revenues517408917684
Total revenues10,0549,17918,67217,328
Operating expenses:
Cost of sales2,8113,0115,5555,979
Research and development1,8681,7443,5873,230
Selling, general and administrative1,7451,6913,3473,378
Other116773907
Total operating expenses6,5406,52312,49213,494
Operating income3,5142,6566,1803,834
Other income (expense):
Interest expense, net(673)(694)(1,330)(1,417)
Other (expense) income, net(73)(394)21,124
Income before income taxes2,7681,5684,8523,541
Provision for income taxes393136658379
Net income$2,375$1,432$4,194$3,162
Earnings per share:
Basic$4.40$2.66$7.77$5.88
Diluted$4.37$2.65$7.71$5.84
Weighted-average shares used in calculation of earnings per share:
Basic540538540538
Diluted544541544541
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.